New IV drug aims to give kidney patients better sleep

This study tests whether a new intravenous drug, Anrikefon, can improve sleep quality better than a standard oral medication (nalfurafine) in people with chronic kidney disease who suffer from severe itching and are on hemodialysis. Fifty adults will receive either Anrikefon injections three times a week or nalfurafine tablets daily for four weeks. The main goal is to see which treatment helps patients sleep better and improves their quality of life.